Distributed Cognition for Improving Cancer Care Coordination

2018 ◽  
Vol 7 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Brian Hazlehurst ◽  
Gurvaneet Randhawa ◽  
Paul N. Gorman ◽  
Yan Xiao
Keyword(s):  
No Value ◽  
Cancer Care ◽  
Distributed Cognition ◽  
Care Process ◽  
Cancer Therapies ◽  
Treatment Technologies ◽  
Cancer Specialists ◽  
The Many ◽  
Effective Use ◽  
Improve Patient

Our health care system uses sophisticated cancer therapies, treatment technologies and facilities, and has dedicated and talented cancer specialists. Effective use of these innovations requires coordination of many diffuse components. For example, transitions between steps of care involve multiple actors and institutions, with distinct sets of information, procedures, policies, practices and knowledge. As Taplin and Rodgers note (2010:108), “[i]t takes the entire care process to achieve optimal cancer care. Screening is of no value without a diagnosis, and diagnosis does not improve outcome without access to comprehensive and effective treatment. This seems obvious but the care process is not studied that way.” In cancer care, coordinating across the many providers and with the patient and family members, is challenging. A human factors and systems-based approach to improving that coordination has potential to improve patient outcomes.

APPLICATION OF THE METHOD SPRINGY DEFORMATIONS OF BARREL DURING SHOT FOR DETERMINING THE INITIAL VELOCITY OF THE SHELL (MINE)

2019 ◽  
Vol 1 (12) ◽  
pp. 75-80
Author(s):  
Ye. Didenko ◽  
O. Stepanenko
Keyword(s):  
Strain Gauge ◽  
Initial Velocity ◽  
Radial Direction ◽  
Fire Control ◽  
Automatic Control Systems ◽  
Measurement Results ◽  
Initial Resistance ◽  
The Moment ◽  
The Many ◽  
Effective Use

One of the indicators of the effective use of artillery is the accuracy of the fire impact on the objects of enemy. The accuracy of the artillery is achieved by completing the implementation of all measures for the preparation of shooting and fire control. Main measures of ballistic preparation are to determine and take into account the summary deviation of the initial velocity. The existing procedure for determining the summary deviation of the initial velocity for the check (main) cannon of battery leads to accumulation of ballistic preparation errors. The supply of artillery units with means of determining the initial speed of the projectile is insufficient. Among the many known methods for measuring the initial velocity, not enough attention was paid to the methods of analyzing the processes that occur during a shot in the "charge-shell-barrel" system. Under the action of the pressure of the powder gases in the barrel channel and the forces of the interaction of the projectile with the barrel there are springy deformations in the radial direction. To measure springy deformations it is advisable to use strain gauge sensors. Monitoring of deformation in a radial direction by time can be used to determine the moment of passing a projectile past the strain gauge mounted on the outer surface of the barrel. In the case of springy deformations, the initial resistance of the sensor varies in proportion to its value. The speed of the shell (mine) in the barrel can be determined by time between pulses of signals obtained from strain gauges located at a known distance from each other. The simplicity of the proposed method for measuring the initial velocity of an artillery shell provides an opportunity for equipping each cannon (mortar) with autonomous means for measuring the initial velocity. With the simultaneous puting into action of automatic control systems can be automatically taking into account the measurement results. This will change the existing procedure for determining the total deviation of the initial velocity and improve the accuracy, timeliness and suddenness of the opening of artillery fire, which are components of its efficiency.

scholarly journals Multidisciplinary Cancer Care With a Patient and Physician Satisfaction Focus

2010 ◽  
Vol 6 (6) ◽  
pp. e35-e37 ◽  
Author(s):  
Gregory Litton ◽  
Dianne Kane ◽  
Gina Clay ◽  
Patricia Kruger ◽  
Thomas Belnap ◽  
...  
Keyword(s):  
Quality Of Care ◽  
Cancer Care ◽  
Physician Satisfaction ◽  
Care Process ◽  
Multidisciplinary Clinic ◽  
Intermountain Healthcare ◽  
Multidisciplinary Clinics

If implemented appropriately, multidisciplinary clinics can enhance quality of care and increase downstream revenue. The multidisciplinary clinic at Intermountain Healthcare has greatly improved the cancer care process for patients, physicians, and the community.

Differences in approach of cancer specialists toward AYA cancer care

2021 ◽  
Author(s):  
Kimikazu Matsumoto ◽  
Kazuhito Yamamoto ◽  
Seiichiro Ozono ◽  
Hiroya Hashimoto ◽  
Keizo Horibe
Keyword(s):  
Cancer Care ◽  
Cancer Specialists

scholarly journals Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care

Radiographics ◽  
2017 ◽  
Vol 37 (5) ◽  
pp. 1371-1387 ◽  
Author(s):  
Mizuki Nishino ◽  
Hiroto Hatabu ◽  
Lynette M. Sholl ◽  
Nikhil H. Ramaiya
Keyword(s):  
Cancer Care ◽  
Cancer Therapies ◽  
New Era ◽  
Practical Guide

scholarly journals Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma

2020 ◽  
Author(s):  
Chuan Li ◽  
Wen-Yang Lin ◽  
Hira Rizvi ◽  
Hongchen Cai ◽  
Christopher D. McFarland ◽  
...  
Keyword(s):  
Cancer Therapies ◽  
Genetic Determinants ◽  
Patient Response ◽  
Large Patient ◽  
Treatment Responses ◽  
Effective Use ◽  
The Relationship ◽  
Robust Statistical Methods ◽  
Therapeutic Responses

Abstract:The lack of knowledge about the relationship between tumor genotypes and therapeutic responses remains one of the most important gaps in enabling the effective use of cancer therapies. Here, we couple a multiplexed and quantitative platform with robust statistical methods to enable pharmacogenomic mapping of lung cancer treatment responses in vivo. We uncover a surprisingly complex map of genotype-specific therapeutic responses, with over 20% of possible interactions showing significant resistance or sensitivity. We validate one of these interactions - the resistance of Keap1 mutant tumors to platinum therapy - using a large patient response dataset. Our results highlight the importance of understanding the genetic determinants of treatment responses in the development of precision therapies and define a strategy to identify such determinants.

Semantic Interoperability Issue of Standardizing Medical Vocabularies

2010 ◽  
pp. 19-42
Author(s):  
W. Ed Hammond
Keyword(s):  
Semantic Interoperability ◽  
Care Process ◽  
Basic Unit ◽  
Quality Healthcare ◽  
Data Interchange ◽  
Worthy Goal ◽  
Improved Performance ◽  
Value Sets ◽  
The Many ◽  
Data Elements

Semantic interoperability is the key to achieving global interoperability in healthcare information technology. The benefits are tremendous – the sharing of clinical data for multiple uses including patient care, research, reimbursement, audit and analyses, education, health surveillance, and many other uses. Patient safety, higher quality healthcare, more effective and efficient healthcare, increased outcomes, and potentially improved performance, higher quality of life and longer lifetimes are potential results. Decision support and the immediate linking of knowledge to the care process become easier. Semantic interoperability is a worthy goal. There are many barriers to achieving semantic interoperability. Key among these is the resolution of the many issues relating to the terminologies used in defining, describing and documenting health care. Each of these controlled terminologies has a reason for being and a following. The terminologies conflict and overlap; the granularity is not sufficiently rich for direct clinical use; there are gaps that prevent an exhaustive set; there are major variances in cost and accessibility; and no one appears eager or willing to make the ultimate decisions required to solve the problem. This chapter defines and describes the purpose and characteristics of the major terminologies in use in healthcare today. Terminology sets are compared in purpose, form and content. Finally, a proposed solution is presented based on a global master metadictionary of data elements with a rich set of attributes including names that may come from existing controlled terminologies, precise definitions to remove ambiguity in use, and complete value sets of possible values. The focus is on data elements because data elements are the basic unit of data interchange.

Health care process and patient experience

2013 ◽  
pp. 384-395
Author(s):  
Diana Delnoij
Keyword(s):  
Health Care ◽  
Quality Of Care ◽  
Patient Experiences ◽  
Care Process ◽  
Negative Experiences ◽  
Patient’S Perspective ◽  
Hands On ◽  
Improve Patient ◽  
Patients Perspective

This chapter will help you to analyse the health care process and, in particular, the quality of this process and its outcomes from the patient’s perspective. You will read how you can measure quality from the patient’s perspective, how to interpret the findings, and how to take action based on the results. This chapter provides hands-on guidance with respect to the development and implementation of surveys measuring patient experiences. However, keep in mind that this is only a first step in the quality cycle. The results of such a survey give you a ‘diagnosis’ of the quality of care from the patients’ perspective. It does not really tell you what you should do to improve patient experiences, however. To find effective remedies for negative experiences, often you will have to do additional research.

The Complex Cancer Care Coverage Environment — What is the Role of Legislation?

2020 ◽  
Vol 48 (3) ◽  
pp. 538-551 ◽  
Author(s):  
Christine Leopold ◽  
Rebecca L. Haffajee ◽  
Christine Y. Lu ◽  
Anita K. Wagner
Keyword(s):  
Cancer Care ◽  
Insurance Coverage ◽  
Cancer Therapeutics ◽  
Health Insurance Coverage ◽  
Cancer Therapies ◽  
Cancer Treatments ◽  
Difficult Situation ◽  
Cell Therapies ◽  
State Laws ◽  
Anti Cancer

Over the past decades, anti-cancer treatments have evolved rapidly from cytotoxic chemotherapies to targeted therapies including oral targeted medications and injectable immunooncology and cell therapies. New anti-cancer medications come to markets at increasingly high prices, and health insurance coverage is crucial for patient access to these therapies. State laws are intended to facilitate insurance coverage of anti-cancer therapies.Using Massachusetts as a case study, we identified five current cancer coverage state laws and interviewed experts on their perceptions of the relevance of the laws and how well they meet the current needs of cancer care given rapid changes in therapies. Interviewees emphasized that cancer therapies, as compared to many other therapeutic areas, are unique because insurance legislation targets their coverage. They identified the oral chemotherapy parity law as contributing to increasing treatment costs in commercial insurance. For commercial insurers, coverage mandates combined with the realities of new cancer medications — including high prices and often limited evidence of efficacy at approval — compound a difficult situation. Respondents recommended policy approaches to address this challenging coverage environment, including the implementation of closed formularies, the use of cost-effectiveness studies to guide coverage decisions, and the application of value-based pricing concepts. Given the evolution of cancer therapeutics, it may be time to evaluate the benefits and challenges of cancer coverage mandates.

Sign in / Sign up

Export Citation Format

Share Document